NM_000372.5:c.346C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000372.5(TYR):c.346C>T(p.Arg116*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000372.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251354Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135848
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727242
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74428
ClinVar
Submissions by phenotype
Oculocutaneous albinism type 1A Pathogenic:3
- -
- -
- -
not provided Pathogenic:2Other:1
This sequence change creates a premature translational stop signal (p.Arg116*) in the TYR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYR are known to be pathogenic (PMID: 23504663). This variant is present in population databases (rs61753256, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with oculocutaneous albinism (PMID: 31077556, 31199599). ClinVar contains an entry for this variant (Variation ID: 99565). For these reasons, this variant has been classified as Pathogenic. -
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31077556, 23324268, 10671066, 26252096, 28507374, 31199599, 34426522, 32552135, 35923705, 28378818, 30996339) -
Oculocutaneous albinism type 1B;C2677190:SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;C4551504:Oculocutaneous albinism type 1A Pathogenic:1
- -
Oculocutaneous albinism type 1B;C2677190:SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;C4551504:Oculocutaneous albinism type 1A;CN028925:Ocular albinism with congenital sensorineural hearing loss Pathogenic:1
- -
TYR-related disorder Pathogenic:1
The TYR c.346C>T variant is predicted to result in premature protein termination (p.Arg116*). This variant has been reported in multiple individuals with oculocutaneous albinism (see for examples: Oetting et al. 1998. PubMed ID: 10671066; Wei et al. 2013. PubMed ID: 23324268; Lin et al. 2019. PubMed ID: 31199599). This variant is reported in 0.025% of alleles in individuals of East Asian descent in gnomAD. Nonsense variants in TYR are an established mechanism of disease. Given the evidence, we interpret this variant as pathogenic. -
Oculocutaneous albinism type 1B;C4551504:Oculocutaneous albinism type 1A Pathogenic:1
PM2_Supporting+PVS1+PM3_Strong+PP4 -
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at